Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial
David Erritzøe, Tommaso Barba, Kyle T. Greenway, Roberta Murphy, Jonny Martell, Bruna Giribaldi, Christopher Timmermann, Ashleigh Murphy-Beiner, Michelle Baker-Jones, David Nutt, Brandon Weiss, Robin Lester Carhart-Harris
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1016/j.eclinm.2024.102799
- Published
- Sep 23, 2024
- Venue
- EClinicalMedicine
- DOI
- 10.1016/j.eclinm.2024.102799
- PubMed
- 39764567
- Categories
- Psychedelics and Drug Studies
- License
- cc-by-nc
- Provenance
- openalex